Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients
作者： Sylvie Lorenzen , Susanne Blank , Florian Lordick , Jörg-Rüdiger Siewert , Katja Ott
DOI: 10.1245/S10434-012-2254-1
关键词:
摘要: Background Response to neoadjuvant chemotherapy is an independent prognostic factor in locally advanced gastric cancer. However, no prospectively tested pretherapeutic parameters predicting response and/or survival cancer are available clinical routine.
springer.com
sci-hub.se 参考文章(68)
Anna Chiaravalli, Matteo Cornaggia, Daniela Furlan, Carlo Capella, Roberto Fiocca, Giovanna Tagliabue, Catherine Klersy, Enrico Solcia, The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Archiv. ,vol. 439, pp. 158- 169 ,(2001) , 10.1007/S004280100441
Hakan Alakus, Arnulf H. Hölscher, Guido Grass, Eva Hartmann, Christian Schulte, Uta Drebber, Stephan E. Baldus, Elfriede Bollschweiler, Ralf Metzger, Stefan P. Mönig, Extracapsular lymph node spread Cancer. ,vol. 116, pp. 309- 315 ,(2010) , 10.1002/CNCR.24764
Karl-Friedrich Becker, Ingrid Becker, Michael J. Atkinson, Jörg R. Siewert, Ulrike Reich, Hjalmar Nekarda, Heinz Höfler, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Research. ,vol. 54, pp. 3845- 3852 ,(1994)
H J Lenz, C G Leichman, K D Danenberg, P V Danenberg, S Groshen, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, Y Garcia, J Li, L Leichman, Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. Journal of Clinical Oncology. ,vol. 14, pp. 176- 182 ,(1996) , 10.1200/JCO.1996.14.1.176
V. Boige, J. Pignon, B. Saint-Aubert, P. Lasser, T. Conroy, O. Bouché, P. Segol, L. Bedenne, P. Rougier, M. Ychou, Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial Journal of Clinical Oncology. ,vol. 25, pp. 4510- 4510 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.4510
Classification of adenocarcinoma of the oesophagogastric junction British Journal of Surgery. ,vol. 85, pp. 1457- 1459 ,(2003) , 10.1046/J.1365-2168.1998.00940.X
J A Ajani, J A Roth, B Ryan, M McMurtrey, T A Rich, D E Jackson, J L Abbruzzese, B Levin, L DeCaro, C Mountain, Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. Journal of Clinical Oncology. ,vol. 8, pp. 1231- 1238 ,(1990) , 10.1200/JCO.1990.8.7.1231
A Marchet, Simone Mocellin, Alessandro Ambrosi, Giovanni de Manzoni, A Di Leo, Daniele Marrelli, Franco Roviello, P Morgagni, L Saragoni, G Natalini, F De Santis, L Baiocchi, Arianna Coniglio, D Nitti, Italian Research Group for Gastric Cancer Study (GIRCG, The prognostic value of N-ratio in patients with gastric cancer: Validation in a large, multicenter series Ejso. ,vol. 34, pp. 159- 165 ,(2008) , 10.1016/J.EJSO.2007.04.018
Katja Ott, Florian Lordick, Ken Herrmann, Bernd-Joachim Krause, Christoph Schuhmacher, Jörg Rüdiger Siewert, The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies. Gastric Cancer. ,vol. 11, pp. 1- 9 ,(2008) , 10.1007/S10120-007-0448-1
D. Vallböhmer, U. Drebber, P.M. Schneider, S. Baldus, E. Bollschweiler, J. Brabender, U. Warnecke-Eberz, S. Mönig, A.H. Hölscher, R. Metzger, Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis Journal of Surgical Oncology. ,vol. 99, pp. 409- 413 ,(2009) , 10.1002/JSO.21271